Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares Issued
Ratios

Akebia Therapeutics (AKBA) Shares Issued: 2016-2025

Historic Shares Issued for Akebia Therapeutics (AKBA) over the last 9 years, with Jun 2025 value amounting to $1.5 million.

  • Akebia Therapeutics' Shares Issued was N/A to $1.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $90.2 million, marking a year-over-year change of. This contributed to the annual value of $42.5 million for FY2024, which is 533.50% up from last year.
  • According to the latest figures from Q2 2025, Akebia Therapeutics' Shares Issued is $1.5 million, which was down 97.62% from $64.9 million recorded in Q1 2025.
  • In the past 5 years, Akebia Therapeutics' Shares Issued ranged from a high of $72.4 million in Q4 2021 and a low of -$1,000 during Q4 2022.
  • Moreover, its 3-year median value for Shares Issued was $4.1 million (2023), whereas its average is $14.5 million.
  • Per our database at Business Quant, Akebia Therapeutics' Shares Issued slumped by 100.00% in 2022 and then surged by 662,500.00% in 2023.
  • Quarterly analysis of 5 years shows Akebia Therapeutics' Shares Issued stood at $72.4 million in 2021, then plummeted by 100.00% to -$1,000 in 2022, then skyrocketed by 662,500.00% to $6.6 million in 2023, then skyrocketed by 233.53% to $22.1 million in 2024, then skyrocketed by 246.36% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q2 2025, $64.9 million for Q1 2025, and $22.1 million during Q4 2024.